RA CAPITAL MANAGEMENT, L.P. Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$6.2T
Holdings
92
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (92 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A/S | 6,806,341 | $895.4B | 14.37% | |
| 2 | NVV1NOVAVAX INC | 2,559,918 | $543.5B | 8.72% | |
| 3 | —FORMA THERAPEUTICS HLDGS INC | 9,011,651 | $224.3B | 3.60% | |
| 4 | JANXJANUX THERAPEUTICS INC | 8,670,644 | $216.3B | 3.47% | |
| 5 | VORVOR BIOPHARMA INC | 11,120,973 | $207.4B | 3.33% | |
| 6 | AVTEAEROVATE THERAPEUTICS INC | 8,263,982 | $188.7B | 3.03% | |
| 7 | NKTXNKARTA INC | 5,605,129 | $177.6B | 2.85% | |
| 8 | MGNXMACROGENICS INC | 5,943,594 | $159.6B | 2.56% | |
| 9 | CNTBCONNECT BIOPHARMA HLDGS LTD | 6,991,003 | $136.5B | 2.19% | |
| 10 | TGTXTG THERAPEUTICS INC | 3,342,743 | $129.7B | 2.08% | |
| 11 | IMGNEURIMMUNOGEN INC | 18,417,458 | $121.4B | 1.95% | |
| 12 | AVIRATEA PHARMACEUTICALS INC | 5,368,451 | $115.3B | 1.85% | |
| 13 | 5E7ITEOS THERAPEUTICS INC | 4,417,259 | $113.3B | 1.82% | |
| 14 | DAWNDAY ONE BIOPHARMACEUTICALS I | 4,965,588 | $113.1B | 1.81% | |
| 15 | AXSMAXSOME THERAPEUTICS INC | 1,655,447 | $111.7B | 1.79% | |
| 16 | PHATPHATHOM PHARMACEUTICALS INC | 3,115,008 | $105.4B | 1.69% | |
| 17 | TILINSTIL BIO INC | 4,870,793 | $94.1B | 1.51% | |
| 18 | RCKTROCKET PHARMACEUTICALS INC COM | 2,107,149 | $93.3B | 1.50% | |
| 19 | ETNBGBP89BIO INC | 4,965,769 | $92.9B | 1.49% | |
| 20 | —ZOGENIX INC | 5,283,976 | $91.3B | 1.47% | |
| 21 | PCVXVAXCYTE INC | 3,865,808 | $87.0B | 1.40% | |
| 22 | —KINNATE BIOPHARMA INC | 3,593,052 | $83.6B | 1.34% | |
| 23 | GRPHGRAPHITE BIO INC | 2,698,369 | $82.9B | 1.33% | |
| 24 | TVTXTRAVERE THERAPEUTICS INC | 5,614,428 | $81.9B | 1.31% | |
| 25 | HOWLWEREWOLF THERAPEUTICS INC | 4,291,881 | $74.8B | 1.20% | |
| 26 | RYTMRHYTHM PHARMACEUTICALS INC | 4,871,067 | $71.1B | 1.14% | |
| 27 | CYTCYTEIR THERAPEUTICS INC | 3,247,117 | $69.5B | 1.12% | |
| 28 | GHRSGH RESEARCH PLC | 2,978,955 | $64.7B | 1.04% | |
| 29 | OLMAOLEMA PHARMACEUTICALS INC | 2,150,404 | $60.2B | 0.97% | |
| 30 | DYNDYNE THERAPEUTICS INC | 2,805,045 | $59.0B | 0.95% | |
| 31 | PMVPPMV PHARMACEUTICALS INC | 1,710,265 | $58.4B | 0.94% | |
| 32 | KALAKALA PHARMACEUTICALS INC | 10,874,613 | $57.6B | 0.93% | |
| 33 | —CURIS INC | 7,140,091 | $57.6B | 0.92% | |
| 34 | CERE1EURCEREVEL THERAPEUTICS HLDNG INC | 2,200,000 | $56.4B | 0.90% | |
| 35 | EWTXEDGEWISE THERAPEUTICS INC | 2,613,623 | $55.7B | 0.89% | |
| 36 | ORTXUSDORCHARD THERAPEUTICS PLC | 12,315,213 | $54.1B | 0.87% | |
| 37 | SPRYSILVERBACK THERAPEUTICS INC | 1,742,186 | $53.8B | 0.86% | |
| 38 | VERVVERVE THERAPEUTICS INC | 880,284 | $53.0B | 0.85% | |
| 39 | CCCCC4 THERAPEUTICS INC | 1,377,569 | $52.1B | 0.84% | |
| 40 | WVEWAVE LIFE SCIENCES LTD | 7,775,207 | $51.8B | 0.83% | |
| 41 | TREURTRILLIUM THERAPEUTICS INC | 5,290,481 | $51.3B | 0.82% | |
| 42 | 698ACHILLES THERAPEUTICS PLC | 5,014,687 | $49.1B | 0.79% | |
| 43 | CCXIEURCHEMOCENTRYX INC | 3,496,639 | $46.8B | 0.75% | |
| 44 | KALVKALVISTA PHARMACEUTICALS INC | 1,930,322 | $46.3B | 0.74% | |
| 45 | ARDXARDELYX INC | 6,077,294 | $46.1B | 0.74% | |
| 46 | SLDBSOLID BIOSCIENCES INC | 12,367,873 | $45.3B | 0.73% | |
| 47 | DSGNDESIGN THERAPEUTICS INC | 2,186,636 | $43.5B | 0.70% | |
| 48 | GONGERON CORP | 30,126,299 | $42.5B | 0.68% | |
| 49 | —SATSUMA PHARMACEUTICALS INC | 5,914,252 | $41.7B | 0.67% | |
| 50 | LEGNLEGEND BIOTECH CORP | 977,503 | $40.1B | 0.64% | |
| 51 | BOLT1EURBOLT BIOTHERAPEUTICS INC | 2,378,325 | $36.8B | 0.59% | |
| 52 | INZYINOZYME PHARMA INC | 2,003,653 | $34.1B | 0.55% | |
| 53 | VRNAVERONA PHARMA PLC | 5,100,000 | $33.4B | 0.54% | |
| 54 | BDTXBLACK DIAMOND THERAPEUTICS INC | 2,589,904 | $31.6B | 0.51% | |
| 55 | —AKOUOS INC | 2,281,249 | $28.6B | 0.46% | |
| 56 | CNTACENTESSA PHARMACEUTICALS PLC | 1,280,300 | $28.4B | 0.46% | |
| 57 | IPSCCENTURY THERAPEUTICS INC | 914,094 | $26.8B | 0.43% | |
| 58 | NAUTNAUTILUS BIOTECHNOLOGY INC | 2,471,430 | $25.0B | 0.40% | |
| 59 | CTMXCYTOMX THERAPEUTICS INC | 3,500,000 | $22.2B | 0.36% | |
| 60 | SCPHSCPHARMACEUTICALS INC | 2,731,170 | $16.7B | 0.27% | |
| 61 | LRMRLARIMAR THERAPEUTICS INC | 1,515,151 | $14.9B | 0.24% | |
| 62 | —BCTG ACQUISITION CORP | 1,250,000 | $14.2B | 0.23% | |
| 63 | ENTXWENTERA BIO LTD | 2,353,000 | $14.1B | 0.23% | |
| 64 | —BCLS ACQUISITION CORP | 1,250,000 | $13.2B | 0.21% | |
| 65 | CNCEEURCONCERT PHARMACEUTICALS INC | 3,033,603 | $12.8B | 0.21% | |
| 66 | —CATABASIS PHARMACEUTICALS IN | 5,947,861 | $12.6B | 0.20% | |
| 67 | MISTMILESTONE PHARMACEUTICALS INC | 2,246,503 | $12.4B | 0.20% | |
| 68 | —THERAPEUTICS ACQUISITION COR | 1,098,318 | $11.3B | 0.18% | |
| 69 | EYPTEYEPOINT PHARMACEUTICALS INC | 1,250,000 | $11.2B | 0.18% | |
| 70 | —ARYA SCIENCES ACQU CORP IV | 1,000,000 | $10.7B | 0.17% | |
| 71 | OCULOCULAR THERAPEUTIX INC | 750,000 | $10.6B | 0.17% | |
| 72 | —PHASEBIO PHARMACEUTICALS INC | 2,850,000 | $10.6B | 0.17% | |
| 73 | —IKENA ONCOLOGY INC | 750,000 | $10.5B | 0.17% | |
| 74 | ORICORIC PHARMACEUTICALS INC | 584,000 | $10.3B | 0.17% | |
| 75 | —FRAZIER LIFESCIENCES ACQUISITION CO | 1,000,000 | $10.1B | 0.16% | |
| 76 | —FS DEVELOPMENT CORP II | 1,000,000 | $10.0B | 0.16% | |
| 77 | —THERAPEUTICSMD INC | 7,812,500 | $9.3B | 0.15% | |
| 78 | CGEMCULLINAN ONCOLOGY INC | 350,000 | $9.0B | 0.14% | |
| 79 | COGTCOGENT BIOSCIENCES INC | 1,025,641 | $8.3B | 0.13% | |
| 80 | BMEABIOMEA FUSION INC | 500,000 | $7.8B | 0.13% | |
| 81 | CVRXCVRX INC | 275,000 | $7.7B | 0.12% | |
| 82 | —5 01 ACQUISITION CORP | 750,000 | $7.5B | 0.12% | |
| 83 | MLTXHELIX ACQUISITION CORP | 700,000 | $7.2B | 0.12% | |
| 84 | —HEALTH SCIENCES ACQ CORP 2 | 625,000 | $6.4B | 0.10% | |
| 85 | VRDNVIRIDIAN THERAPEUTICS INC | 312,328 | $5.7B | 0.09% | |
| 86 | —SYROS PHARMACEUTICALS INC | 900,000 | $4.9B | 0.08% | |
| 87 | —AERPIO PHARMACEUTICALS INC | 2,693,309 | $4.6B | 0.07% | |
| 88 | —CEREVEL THERAPEUTICS HLDNG INC | 233,333 | $3.4B | 0.05% | |
| 89 | NTLAINTELLIA THERAPEUTICS INC | 15,000 | $2.4B | 0.04% | |
| 90 | —IMARA INC | 248,804 | $2.0B | 0.03% | |
| 91 | MCRB1EURSERES THERAPEUTICS INC | 5,105,547 | $1.9B | 0.03% | |
| 92 | OKURRENEO PHARMACEUTICALS INC | 62,217 | $580.0M | 0.01% |